NCT04743661 2026-02-05
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Pediatric Brain Tumor Consortium
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT07346157 2026-01-16
PNOC044
University of California, San Francisco
Phase 1/2 Not yet recruiting
NCT05017610 2022-12-02
Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
Emory University
Phase EARLY_PHASE1 Withdrawn
NCT00488644 2013-06-24
Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors
M.D. Anderson Cancer Center
Phase NA Terminated